57 related articles for article (PubMed ID: 8139101)
1. [Successful treatment of chemotherapy-resistant adult T cell leukemia/lymphoma by irinotecan hydrochloride (CPT-11)].
Makino T; Nakahara K; Takatsuka Y; Shimotakahara S; Utsunomiya A; Hanada S; Tokunaga M; Arima T
Rinsho Ketsueki; 1994 Jan; 35(1):42-8. PubMed ID: 8139101
[TBL] [Abstract][Full Text] [Related]
2. [Late phase II clinical study of irinotecan hydrochloride (CPT-11) in the treatment of malignant lymphoma and acute leukemia. The CPT-11 Research Group for Hematological Malignancies].
Ota K; Ohno R; Shirakawa S; Masaoka T; Okada K; Ohashi Y; Taguchi T
Gan To Kagaku Ryoho; 1994 Jun; 21(7):1047-55. PubMed ID: 8210256
[TBL] [Abstract][Full Text] [Related]
3. Treatment of adult T-cell leukaemia-lymphoma with irinotecan hydrochloride (CPT-11). CPT-11 Study Group on Hematological Malignancy.
Tsuda H; Takatsuki K; Ohno R; Masaoka T; Okada K; Shirakawa S; Ohashi Y; Ota K
Br J Cancer; 1994 Oct; 70(4):771-4. PubMed ID: 7917938
[TBL] [Abstract][Full Text] [Related]
4. [Successful salvage therapy of continuous low-dose irinotecan for a patient with relapsed and refractory diffuse large B-cell lymphoma].
Masaki Y; Sawaki T; Shimoyama K; Karasawa H; Kawanami T; Fukushima T; Kawabata H; Ogawa N; Wano Y; Sugai S; Hirose Y; Umehara H
Rinsho Ketsueki; 2005 Sep; 46(9):1074-7. PubMed ID: 16440768
[TBL] [Abstract][Full Text] [Related]
5. [Successful treatment of refractory mantle cell lymphoma with irinotecan].
Hara S; Yokote T; Akioka T; Oka S; Yamano T; Tsuji M; Hanafusa T
Rinsho Ketsueki; 2005 May; 46(5):358-62. PubMed ID: 16444969
[TBL] [Abstract][Full Text] [Related]
6. [Development of acute type, CD 8 positive adult T-cell leukemia in a carrier of hepatitis B virus--possible therapeutic effect of lamivudine combined with chemotherapy].
Nagasaki A; Taira N; Tomoyose T; Miyagi T; Nakachi S; Shinzato O; Hasegawa H; Takasu N
Gan To Kagaku Ryoho; 2006 May; 33(5):683-6. PubMed ID: 16685173
[TBL] [Abstract][Full Text] [Related]
7. [Adult T-cell leukemia/lymphoma in a patient on hemodialysis-resistance to CHOP, but unexpected effect and remission achieved by sobuzoxane alone].
Sakai C; Murotani N
Gan To Kagaku Ryoho; 2010 Feb; 37(2):347-50. PubMed ID: 20154500
[TBL] [Abstract][Full Text] [Related]
8. An early phase II study of CPT-11: a new derivative of camptothecin, for the treatment of leukemia and lymphoma.
Ohno R; Okada K; Masaoka T; Kuramoto A; Arima T; Yoshida Y; Ariyoshi H; Ichimaru M; Sakai Y; Oguro M
J Clin Oncol; 1990 Nov; 8(11):1907-12. PubMed ID: 2230878
[TBL] [Abstract][Full Text] [Related]
9. [Late phase II study of irinotecan hydrochloride (CPT-11) in advanced gastric cancer. CPT-11 Gastrointestinal Cancer Study Group].
Futatsuki K; Wakui A; Nakao I; Sakata Y; Kambe M; Shimada Y; Yoshino M; Taguchi T; Ogawa N
Gan To Kagaku Ryoho; 1994 Jun; 21(7):1033-8. PubMed ID: 8210254
[TBL] [Abstract][Full Text] [Related]
10. [Successful treatment with CPT-11 and adriamycin for hemophagocytic syndrome associated with intravascular lymphomatosis].
Ise M; Sakai C; Tsujimura H; Kumagai K; Takenouchi T; Takagi T
Rinsho Ketsueki; 1998 Nov; 39(11):1131-6. PubMed ID: 9866427
[TBL] [Abstract][Full Text] [Related]
11. Phase I clinical trial of irinotecan (CPT-11), 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothecin, and cisplatin in combination with fixed dose of vindesine in advanced non-small cell lung cancer.
Shinkai T; Arioka H; Kunikane H; Eguchi K; Sasaki Y; Tamura T; Ohe Y; Oshita F; Nishio M; Karato A
Cancer Res; 1994 May; 54(10):2636-42. PubMed ID: 8168091
[TBL] [Abstract][Full Text] [Related]
12. [EPOCH therapy for relapsed/refractory lymphoid malignancies].
Dobashi N; Usui N; Kobayashi T; Yamazaki H; Asai O; Yano S; Kato A; Watanabe H; Nagamine M; Katori M; Tajima N; Kuraishi Y
Rinsho Ketsueki; 1998 Apr; 39(4):267-72. PubMed ID: 9597893
[TBL] [Abstract][Full Text] [Related]
13. A case of post-mogamulizumab relapse of acute-type adult T-cell leukemia/lymphoma successfully treated with mogamulizumab and etoposide.
Sekiguchi Y; Shimada A; Ichikawa K; Wakabayashi M; Sugimoto K; Kinoshita A; Suga Y; Tomita S; Izumi H; Nakamura N; Sawada T; Ohta Y; Komatsu N; Noguchi M
Int J Clin Exp Pathol; 2014; 7(9):6278-90. PubMed ID: 25337281
[TBL] [Abstract][Full Text] [Related]
14. [Two cases of adult T-Cell leukemia/lymphoma with main lesion in stomach treated by VCAP-AMP-VECP regimen].
Ishizuka Y; Ozawa S; Tsuchiya S; Shirai Y; Katoh K; Ohtsuka Y; Komatsu T; Fukazawa M; Takahashi M
Gan To Kagaku Ryoho; 2012 Nov; 39(11):1743-7. PubMed ID: 23152032
[TBL] [Abstract][Full Text] [Related]
15. Phase I and pharmacological study of the novel topoisomerase I inhibitor 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11) administered as a ninety-minute infusion every 3 weeks.
Rowinsky EK; Grochow LB; Ettinger DS; Sartorius SE; Lubejko BG; Chen TL; Rock MK; Donehower RC
Cancer Res; 1994 Jan; 54(2):427-36. PubMed ID: 8275479
[TBL] [Abstract][Full Text] [Related]
16. [Adult T cell leukemia/lymphoma effectively treated with chronic oral etoposide].
Yamane T; Ohta K; Nakao Y; Yasui Y; Shindo K; Tanaka K; Hasuike T; Hirai M; Takekawa K; Hirai N
Gan To Kagaku Ryoho; 1993 Sep; 20(12):1853-6. PubMed ID: 8379679
[TBL] [Abstract][Full Text] [Related]
17. [Effect of chemotherapy using irinotecan (CPT-11) against recurrent colorectal cancer].
Nishimura G; Satou T; Yoshimitsu Y; Kurosaka Y; Fujimura T; Sugiyama K; Kanno M; Yonemura Y; Miwa K; Miyazaki I
Gan To Kagaku Ryoho; 1995 Jan; 22(1):93-7. PubMed ID: 7826085
[TBL] [Abstract][Full Text] [Related]
18. [A late phase II study of CPT-11, irinotecan hydrochloride, in patients with advanced pancreatic cancer. CPT-11 Study Group on Gastrointestinal Cancer].
Sakata Y; Shimada Y; Yoshino M; Kambe M; Futatsuki K; Nakao I; Ogawa N; Wakui A; Taguchi T
Gan To Kagaku Ryoho; 1994 Jun; 21(7):1039-46. PubMed ID: 8210255
[TBL] [Abstract][Full Text] [Related]
19. [An early phase II study of CPT-11 (irinotecan hydrochloride) in patients with advanced breast cancer].
Taguchi T; Yoshida Y; Izuo M; Ishida T; Ogawa M; Nakao I; Tominaga T; Ohkawa T; Oguro M; Yoshida M
Gan To Kagaku Ryoho; 1994 Jan; 21(1):83-90. PubMed ID: 8291919
[TBL] [Abstract][Full Text] [Related]
20. Complete remission in two cases of adult T-cell leukemia/lymphoma treated with hyper-CVAD: a case report and review of the literature.
Alduaij A; Butera JN; Treaba D; Castillo J
Clin Lymphoma Myeloma Leuk; 2010 Dec; 10(6):480-3. PubMed ID: 21156467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
